Quadrivalent Market Report 2026

Quadrivalent Market Overview

• Quadrivalent market size has reached to $9.51 billion in 2025 • Expected to grow to $15.37 billion in 2030 at a compound annual growth rate (CAGR) of 10.1% • Growth Driver: Global Immunization Coverage Surge Propels Quadrivalent Market Growth • Market Trend: Increasing Focus On Product Innovations To Provide Reliable Services To Their Customers • North America was the largest region in 2025.

What Is Covered Under Quadrivalent Market?

Quadrivalent is a vaccination that stimulates the immune system to respond to distinct antigens, such as four different viruses or bacteria. A quadrivalent vaccination is intended to protect against four distinct flu viruses, two of which are type A and type B. The main types of quadrivalent are intradermal shots, intramuscular injections, and nasal sprays. An intradermal shot refers to the vaccine that is injected between the epidermis and hypodermis, often known as the top and bottom layers of the skin, according to the Center For Disease Control (CDC). It is prepared by various technologies including conjugated, live, inactivated, recombinant, toxoid, and others for immunization against cancer, hepatitis, pneumococcal disease, COVID-19, influenza, human papillomavirus, meningococcal disease, polio, rotavirus, and other diseases of pediatric and adult age groups. They are distributed through hospital and pharmacy, government suppliers, and other channels.

What Is The Quadrivalent Market Growth Forecast?

The quadrivalent market size is expected to see rapid growth in the next few years. It will grow to $15.37 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to rising demand for broader influenza protection, innovations in vaccine delivery technologies, expansion of immunization programs in emerging markets, increasing investments in biotech and precision medicine, favorable reimbursement policies and government support. Major trends in the forecast period include vaccine formulation optimization, expanded age group immunization programs, cold chain and distribution innovations, multi-strain influenza coverage, regulatory compliance and quality assurance.

Global Quadrivalent Market Segmentation

1) By Type: Intradermal Shot, Intramuscular Injection, Nasal Spray 2) By Technology: Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies 3) By Disease: Cancer, Hepatitis, Pneumococcal Disease, COVID-19, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Other Diseases 4) By Age Group: Pediatric, Adult 5) By Distribution Channel: Hospital And Pharmacy, Government Suppliers, Other Channels (NGOs) Subsegments: 1) By Intradermal Shot: Standard Intradermal Injection, Needle-Free Intradermal Delivery 2) By Intramuscular Injection: Standard Intramuscular Injection, Adjuvanted Intramuscular Injection 3) By Nasal Spray: Live Attenuated Nasal Spray, Inactivated Nasal Spray

What Is The Driver Of The Quadrivalent Market?

Rising immunization coverage across the world is expected to propel a quadrivalent market. Immunization coverage refers to the proportion of a population that has received specific vaccines or a set of recommended vaccines within a specified time frame. Expanding immunization coverage drives increased demand for vaccines, with quadrivalent vaccines, offering protection against four strains, frequently integrated into routine vaccination programs to address multiple disease threats in a single shot. For instance, in July 2025, according to the World Health Organization, a Switzerland-based international public health organization, reported that global coverage for the first dose of the HPV vaccine in girls grew from 27% in 2023 to 31% in 2024. Therefore, rising immunization coverage across the world will drive quadrivalent industry growth going forward.

Key Players In The Global Quadrivalent Market

Major companies operating in the quadrivalent market are AstraZeneca Plc, Serum Institute of India Private Limited, Sanofi S.A., GlaxoSmithKline Plc, CSL Limited, Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Pfizer Inc., Walvax Biotechnology Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Biological E. Limited, GSK Biologicals SA, Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences, Wuhan Institute of Biological Products Co. Ltd., Beijing Tian Tan Biological Products Co. Ltd., Shanghai Zhijiang Bio-pharm Co. Ltd., Bio Farma, Butantan Institute, Pasteur Institute of India, China National Biotec Group Co. Ltd. (CNBG)

Global Quadrivalent Market Trends and Insights

Major companies operating in the quadrivalent market are focusing on safer, innovative vaccine delivery technologies such as nano-particle technology to drive revenues in their market. The nano-particle technology mimics the virus's external structure using virus-like particles (VLPs) without containing live genetic material, enhancing safety and immune response. For instance, in March 2024, Cadila Pharmaceuticals, an India-based pharmaceutical company, launched the advanced Quadrivalent Influenza Vaccine, a sophisticated immunization designed to provide protection against four distinct strains of the influenza virus such as two A strains (H1N1 and H3N2) and two B strains. This quadrivalent formulation enhances the vaccine's efficacy by targeting a broader range of circulating influenza viruses, making it especially effective during flu seasons. The aQIV aims to stimulate a robust immune response, reducing the incidence of influenza-related morbidity and mortality. Its development reflects ongoing efforts to improve public health outcomes in the face of evolving viral strains.

What Are Latest Mergers And Acquisitions In The Quadrivalent Market?

In February 2023, Clover Biopharmaceuticals Ltd. a China-based biotechnology company partnered with Adimmune Corporation. Through this partnership, Adimmune's manufacturing and distribution experience of vital vaccines to Asian populations will be utilized. This is in line with Clover's objective of becoming a premier respiratory vaccine franchise and achieving synergies with the ongoing COVID-19 vaccine commercialization. Adimmune Corporation is a Taiwan -based biopharmaceutical company.

Regional Insights

North America was the largest region in the quadrivalent market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Quadrivalent Market?

The quadrivalent market consists of sales of afluria quadrivalent, fluarix quadrivalent, flublok quadrivalent, fluzone quadrivalent (influenza virus vaccine), flulaval quadrivalent, flucelvax quadrivalent, menactra and menveo. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Quadrivalent Market Report 2026?

The quadrivalent market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the quadrivalent industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.